Experts say U.S. must step up to match Europe’s progress in eliminating hepatitis C

The authors argue that England and several other nations are nearing hepatitis C elimination, while the United States lags behind.

They point to recent public attention, such as Pamela Anderson’s disclosure of her 1990s hepatitis C diagnosis and the grim prognosis she received, to show how treatment perceptions have changed.

The piece reminds readers that hepatitis C is a blood‑borne infection that can cause chronic liver damage, cirrhosis and end‑stage liver disease, and that most cases require medical therapy to clear.

The authors call for serious investment and coordinated public‑health action in the U.S. to catch up with European progress and achieve elimination.